09.15.15
Fort Worth, Texas-based CoorsTek Medical Inc. has initiated a five-year, multi-million dollar capital investment program to support the growing worldwide demand for its ceramic hip replacement components and turn-key hip arthroplasty solutions. The investment funds a twenty-fold production expansion of these products as major medical device manufacturers adopt the company’s Cerasurf medical-grade ceramics.
CoorsTek’s Cerasurf alumina matrix composite is both CE-compliant and substantially equivalent to the latest generation material used in ceramic hip implants today. Since 2011 more than 7,000 Cerasurf hip balls and acetabular liners have been sold for distribution across key global markets.
CoorsTek produces critical-duty products and components for 10,000 customers from its portfolio of more than 300 advanced materials. CoorsTek Medical provides specialized OEM medical device solutions designed around durable, biocompatible ceramic technology, delivering more than 1 million components annually to global medical device manufacturers.
“As we engage medical innovators and key opinion leaders globally, they are applying the unique, high performance benefits of our ceramic materials to improve the longevity and lifestyle for more patients each year,” explained Jonathan Coors, CEO of CoorsTek Medical. “Our valued partners deserve a choice and will be successful with a trusted partner who embraces today’s dynamic healthcare economy. This investment demonstrates the CoorsTek Medical commitment to being that partner of choice for implant-grade ceramic materials which make lives measurably better.”
CoorsTek Medical is a medical component and product manufacturer that offers the full supply chain of device development services from conception to realization.
CoorsTek’s Cerasurf alumina matrix composite is both CE-compliant and substantially equivalent to the latest generation material used in ceramic hip implants today. Since 2011 more than 7,000 Cerasurf hip balls and acetabular liners have been sold for distribution across key global markets.
CoorsTek produces critical-duty products and components for 10,000 customers from its portfolio of more than 300 advanced materials. CoorsTek Medical provides specialized OEM medical device solutions designed around durable, biocompatible ceramic technology, delivering more than 1 million components annually to global medical device manufacturers.
“As we engage medical innovators and key opinion leaders globally, they are applying the unique, high performance benefits of our ceramic materials to improve the longevity and lifestyle for more patients each year,” explained Jonathan Coors, CEO of CoorsTek Medical. “Our valued partners deserve a choice and will be successful with a trusted partner who embraces today’s dynamic healthcare economy. This investment demonstrates the CoorsTek Medical commitment to being that partner of choice for implant-grade ceramic materials which make lives measurably better.”
CoorsTek Medical is a medical component and product manufacturer that offers the full supply chain of device development services from conception to realization.